DVAX
DYNAVAX TECHNOLOGIES CORP
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$15.50
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+0.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 10, 2026 | Spencer Ryan · director, officer: CEO and Director | A-Award | 165,000 | $0.00 |
| Feb 10, 2026 | Novack David F · officer: President & COO | A-Award | 56,364 | $0.00 |
| Feb 10, 2026 | MacDonald Kelly · officer: SVP and CFO | A-Award | 46,430 | $0.00 |
| Feb 10, 2026 | MacDonald Kelly · officer: SVP and CFO | A-Award | 42,424 | $0.00 |
| Feb 10, 2026 | Slebir John L · officer: SVP General Counsel | A-Award | 50,000 | $0.00 |
| Feb 10, 2026 | Novack David F · officer: President & COO | A-Award | 67,860 | $0.00 |
| Feb 10, 2026 | Slebir John L · officer: SVP General Counsel | A-Award | 42,424 | $0.00 |
| Feb 10, 2026 | Spencer Ryan · director, officer: CEO and Director | A-Award | 136,000 | $0.00 |
| Jan 20, 2026 | Novack David F · officer: President & COO | M-Exempt | 94,000 | $10 |
| Jan 20, 2026 | Novack David F · officer: President & COO | Sale | 114,000 | $16 |
| Jan 20, 2026 | Novack David F · officer: President & COO | M-Exempt | 20,000 | $6.80 |
| Jan 20, 2026 | Novack David F · officer: President & COO | M-Exempt | 8,345 | $10 |
| Dec 29, 2025 | Slebir John L · officer: SVP General Counsel | A-Award | 33,750 | $0.00 |
| Dec 29, 2025 | MacDonald Kelly · officer: SVP and CFO | A-Award | 37,500 | $0.00 |
| Dec 29, 2025 | MacDonald Kelly · officer: SVP and CFO | M-Exempt | 15,477 | $0.00 |
| Dec 29, 2025 | Novack David F · officer: President & COO | A-Award | 60,625 | $0.00 |
| Dec 29, 2025 | Novack David F · officer: President & COO | M-Exempt | 10,000 | $10 |
| Dec 29, 2025 | Slebir John L · officer: SVP General Counsel | M-Exempt | 16,667 | $0.00 |
| Dec 29, 2025 | Novack David F · officer: President & COO | F-InKind | 48,107 | $15 |
| Dec 29, 2025 | MacDonald Kelly · officer: SVP and CFO | M-Exempt | 14,141 | $0.00 |
| Dec 29, 2025 | Novack David F · officer: President & COO | M-Exempt | 20,000 | $6.80 |
| Dec 29, 2025 | Metzinger Joseph Anthony · officer: VP, Chief Accounting Officer | F-InKind | 5,598 | $15 |
| Dec 29, 2025 | Novack David F · officer: President & COO | M-Exempt | 18,788 | $0.00 |
| Dec 29, 2025 | Metzinger Joseph Anthony · officer: VP, Chief Accounting Officer | M-Exempt | 12,727 | $0.00 |
| Dec 29, 2025 | Spencer Ryan · director, officer: CEO and Director | A-Award | 156,250 | $0.00 |
| Dec 29, 2025 | Novack David F · officer: President & COO | Sale | 30,000 | $15 |
| Dec 29, 2025 | Spencer Ryan · director, officer: CEO and Director | M-Exempt | 45,333 | $0.00 |
| Dec 29, 2025 | Spencer Ryan · director, officer: CEO and Director | M-Exempt | 55,000 | $0.00 |
| Dec 29, 2025 | Slebir John L · officer: SVP General Counsel | F-InKind | 32,502 | $15 |
| Dec 29, 2025 | Novack David F · officer: President & COO | M-Exempt | 22,620 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 0Sold out 4
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Essential Partners LLC | Sold Out | 0 | May 21, 2026 |
| National Philanthropic Trust | Sold Out | 0 | May 15, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 27, 2026 |
| Transmarket Holdings LP | Sold Out | 0 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 10, 2026